BSECompany Update4d ago · 7 Aug 2026, 12:36 pm

Newspaper publication- un-audited finacial results

Suven Life Sciences Ltd · 530239

✦ AI SummaryResults

Suven Life Sciences Ltd has published its un-audited financial results for the quarter ended June 30, 2026, showing a net loss of Rs. 1611.91 lakhs for the period.

Analysis Scores

Earnings Impact1/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment3/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

64f3d29f-ee1c-48d8-9c81-f64da9a094d5.pdf

pdf

Download →
View document text
SUVEN® Life Sciences CSD/BM/SE/2026-27 Date: August 7, 2026 To To Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 530239 Scrip Symbol: SUVEN Dear Sir/Madam, Sub: Newspaper advertisement – Un-audited Financial Results Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed copies of newspaper advertisements regarding un-audited financial results of the Company for the quarter ended June 30, 2026. The advertisements appeared in Andhra Prabha (Telugu) and Business Standard (English) on 7th August, 2026. The above information is also available at : https://www.suven.com/newspaperads.aspx This is for your information and records. Thanking you. Yours faithfully, For Suven Life Sciences Limited K. Sangeetha Laxmi Company Secretary and Compliance officer Encl: as above Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com ,ib~7-8-2026 a... a... ~~Oc! s-c-g1:,@o: 8-2-334, .:l~~:R ~~5 ij)"oa.i5;i, 6~ ~oc!~. 11~ o.5, e,;,~£ 7, a.io.::-0"".l'J.), 500 034, 01:,011'~, :RO~@. ~.o.)5: .)e5"24110~l!l1989~.)~009713 &'l!l: 91 40 2354 1142 / 1152 zi-';3.o;i;ie5°: investorservices@suven.com, ~~!:!~' www.suven.com 30 ~~. 2026ga ~a,(6 !cfuaa,~ §°at5~ ~ i.5'a1>&> ~ 30/06/2026 31/03/2026 30/06/2025 30/06/2026 31/03/2026 30/06/2025 iOO. 1 ~tooa~ecad1>o 356.58 711.47 186.67 356.58 711.47 186.67 2 ~tll<IO~~~ (1611.91) (5486.28) (1477.87) (12761.03) (27634.41) (5151.69) 3 lll!O<llCl<>~~m=c (1611.91) (5486.28) (1477.87) (12761.03) (27634.41) (5151.69) 4 &ll!l:)""10so.,ag,A_~~ c ,m (1611.91) (5486.28) (1477.87) (12761.03) (27634.41) (5151.69) lL\lfJa1}.)/.S:,. ~WO<l~) 5 ~~~eaod (1617.46) (5508.47) (1479.37) (12764.63) (27752.80) (5156.81) 6 ~ illb ~ 2639.93 2637.20 2180.74 2637.20 2639.93 2180.74 7 ~~(6~~~ 147699.51 56502.76 8 ~iil>P~ C0,..1/-..:,,-'~) 1.&I: " (0.61) (2.41) (0.68) (4.84) (12.13) (2.36) 2.~: (0.61) (2.41) (0.68) (4.84) (12.13) (2.36) &, : ~ 06, 2026 ~:00278028 Busines Stand rd HYDERABAD I FRIDAY, 1 AuGusr 2026 SUVEN LIFE SCIENCES LIMITED Regd Office: 8-2-334, SD£ Serene Chambers, 6th Floor Road No. 5, Avenue 7, BanJara Hills, 500 034, Telangana, India. CIN: 1.241 l0TGl 989PLC009713 Tel: 9140 2354 1142 / 1152 Email: mvestorservices(asuven com Website: www.suven com EXTRACT OF UN-AUDITED STANDALONE & CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED 30 JUNE, 2026 (? in Lakh,1 STANDAWNE CONSOLIDATED SI. Qtr Ended Year Ended Qtr Ended Qtr Ended Year Ended Qtr Ended I Particulars No. 30/06/2026 31/03/2026 30/06/2025 30/06/2026 31/03/2026 30/06/2025 Un-Audited Audited Un-Audited Un-Audited Audited Un-Audited 1 Total income from operations 356.58 711.47 186.67 356.58 711.47 186.67 I 2 Net profit for the period (before tax, (1611.91) (548628) (147787) (12761.03) (2763441) (5151.69) exceptional and/or extraordinary items) 3 Net profit for the period before tax (after (1611.91) (5486.28) (1477.87) (12761.03) (27634.41) (515169) exceptional and/or extraordinary items) 4 Net profit for the period After tax (after (1611.91) (5486.28) (1477.87) (12761.03) (27634.41) (5151.69) exceptional and/or extraordinary items) 5 Total comprehensive income for the (1617 46) (5508.47) (1479.37) (1276463) (27752.80) (515681) perioa [comprising profit for the period (after tax) and other comprehensive income (after tax) 6 Equity share capital 2639.93 2637.20 2180.74 2637.20 2639.93 2180.74 7 Other Equity (Excluding Revaluation 147699.51 56502.76 Reserve) as shown in the audited balance sheet 8 Earnings Per Share (of Rs. 1.00/-each) 1. Basic (0.61) (2.41) (068) (4.84) (12.13) (2.36) 2. Diluted (061) (2.41) (0.68) (4.84) (12.13) (2.36) (not annualised) (annualised) (not annualised) (not annualised) (annualised) (not annualised) Note: The above is an extract of the detailed format of Quarterly / Annual Rnancial Results filed with the Stock Exchanges under Regulation 33 of the SEBI (Llsting and Other Disclosure Requirements) Regulations, 2015. The full format of the Quarterly/ Annual Rnancial Results are available on the websites of the stock exchanges(s) and the listed entity. (www.bseindia.com and www.nseindia.com) and company's website www.suven.com. You may refer QR code given below to dowhload full results. For SUVEN LIFE SCIENCES LID ■: Sd/ 'Iii VENKAT JASTI Place : Hyderabad I,, Chairman & MD Date : August 06, 2026 I!] •. DIN: 00278028